From: Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
Related factor | N | CIP2A | P | NLR | P | ||
---|---|---|---|---|---|---|---|
Low | High |  < 2.03 | ≧ 2.03 | ||||
Gender | 0.052 | 0.509 | |||||
Female | 30 | 20 | 10 | 18 | 12 | ||
Male | 31 | 13 | 18 | 16 | 15 | ||
Age | 0.052 | 0.509 | |||||
 ≥ 65 | 31 | 13 | 18 | 16 | 15 | ||
 < 65 | 30 | 20 | 10 | 18 | 12 | ||
Location | 0.046 | 0.062 | |||||
Colon | 33 | 14 | 19 | 22 | 11 | ||
Rectum | 28 | 19 | 9 | 12 | 16 | ||
T stage | 0.660 | 0.405 | |||||
T1–T2 | 33 | 17 | 16 | 20 | 13 | ||
T3–T4 | 28 | 16 | 12 | 14 | 14 | ||
N stage | 0.339 | 0.149 | |||||
N0 | 42 | 21 | 21 | 26 | 16 | ||
N1–N2 | 19 | 12 | 7 | 8 | 11 | ||
M stage | 0.076 | 0.265 | |||||
M0 | 53 | 31 | 22 | 31 | 22 | ||
M1 | 8 | 2 | 6 | 3 | 5 | ||
Intestinal obstruction | 0.766 | 0.682 | |||||
No | 51 | 28 | 23 | 27 | 24 | ||
Yes | 10 | 6 | 4 | 6 | 4 | ||
CEA | 0.037 | 0.990 | |||||
 ≥ 5 | 52 | 31 | 21 | 29 | 23 | ||
 < 5 | 9 | 2 | 7 | 5 | 4 | ||
CA19-9 | 0.115 | 0.268 | |||||
 ≥ 37 | 47 | 28 | 19 | 28 | 19 | ||
 < 37 | 14 | 5 | 9 | 6 | 8 |